Trial · NCT07072793
Outcomes42
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 20 of 42
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Number of Participants According to Age Group: Unmatched Participants | At index date (any date during index date identification period of approximately 11.5 months); retrospective data collected was evaluated in 0.5 months of this study | Analysis population included all eligible participants whose data were retrieved and observed in this study. This outcome measure was planned to be reported for unmatched participants (treated and untreated). | Participants | COUNT_OF_PARTICIPANTS |
| PRIMARY | Number of Participants According to Age Group: Matched Participants | At index date (any date during index date identification period of approximately 11.5 months); retrospective data collected was evaluated in 0.5 months of this study | Analysis population included all eligible participants whose data were retrieved and observed in this study. This outcome measure was planned to be reported for matched participants (treated and untreated). Here, Overall Number of Participants Analyzed signifies the numbers which were matched/ adjusted based on pre-defined characteristics among actual enrolled population and was a pseudo population, hence these numbers are different from unmatched population (actual enrolled population). | Participants | COUNT_OF_PARTICIPANTS |
| PRIMARY | Number of Participants According to Sex: Unmatched Participants | At index date (any date during index date identification period of approximately 11.5 months); retrospective data collected was evaluated in 0.5 months of this study | Analysis population included all eligible participants whose data were retrieved and observed in this study. This outcome measure was planned to be reported for unmatched participants (treated and untreated). | Participants | COUNT_OF_PARTICIPANTS |
| PRIMARY | Number of Participants According to Sex: Matched Participants | At index date (any date during index date identification period of approximately 11.5 months); retrospective data collected was evaluated in 0.5 months of this study | Analysis population included all eligible participants whose data were retrieved and observed in this study. This outcome measure was planned to be reported for matched participants (treated and untreated). Here, Overall Number of Participants Analyzed signifies the numbers which were matched/ adjusted based on pre-defined characteristics among actual enrolled population and was a pseudo population, hence these numbers are different from unmatched population (actual enrolled population). | Participants | COUNT_OF_PARTICIPANTS |
| PRIMARY | Number of Participants According to Region of Residence: Unmatched Participants | At index date (any date during index date identification period of approximately 11.5 months); retrospective data collected was evaluated in 0.5 months of this study | Analysis population included all eligible participants whose data were retrieved and observed in this study. This outcome measure was planned to be reported for unmatched participants (treated and untreated). | Participants | COUNT_OF_PARTICIPANTS |
| PRIMARY | Number of Participants According to Region of Residence: Matched Participants | At index date (any date during index date identification period of approximately 11.5 months); retrospective data collected was evaluated in 0.5 months of this study | Analysis population included all eligible participants whose data were retrieved and observed in this study. This outcome measure was planned to be reported for matched participants (treated and untreated). Here, Overall Number of Participants Analyzed signifies the numbers which were matched/ adjusted based on pre-defined characteristics among actual enrolled population and was a pseudo population, hence these numbers are different from unmatched population (actual enrolled population). | Participants | COUNT_OF_PARTICIPANTS |
| PRIMARY | Number of Participants According to Payer Type: Unmatched Participants | At index date (any date during index date identification period of approximately 11.5 months); retrospective data collected was evaluated in 0.5 months of this study | Analysis population included all eligible participants whose data were included and observed in this study. This outcome measure was planned to be reported for unmatched participants (treated and untreated). | Participants | COUNT_OF_PARTICIPANTS |
| PRIMARY | Number of Participants According to Payer Type: Matched Participants | At index date (any date during index date identification period of approximately 11.5 months); retrospective data collected was evaluated in 0.5 months of this study | Analysis population included all eligible participants whose data were retrieved and observed in this study. This outcome measure was planned to be reported for matched participants (treated and untreated). Here, Overall Number of Participants Analyzed signifies the numbers which were matched/ adjusted based on pre-defined characteristics among actual enrolled population and was a pseudo population, hence these numbers are different from unmatched population (actual enrolled population). | Participants | COUNT_OF_PARTICIPANTS |
| PRIMARY | Number of Participants According to Insurance Plan Type: Unmatched Participants | At index date (any date during index date identification period of approximately 11.5 months); retrospective data collected was evaluated in 0.5 months of this study | Analysis population included all eligible participants whose data were included and observed in this study. This outcome measure was planned to be reported for unmatched participants (treated and untreated). | Participants | COUNT_OF_PARTICIPANTS |
| PRIMARY | Number of Participants According to Insurance Plan Type: Matched Participants | At index date (any date during index date identification period of approximately 11.5 months); retrospective data collected was evaluated in 0.5 months of this study | Analysis population included all eligible participants whose data were retrieved and observed in this study. This outcome measure was planned to be reported for matched participants (treated and untreated). Here, Overall Number of Participants Analyzed signifies the numbers which were matched/ adjusted based on pre-defined characteristics among actual enrolled population and was a pseudo population, hence these numbers are different from unmatched population (actual enrolled population). | Participants | COUNT_OF_PARTICIPANTS |
| PRIMARY | Number of Participants According to Industry Type: Unmatched Participants | At index date (any date during index date identification period of approximately 11.5 months); retrospective data collected was evaluated in 0.5 months of this study | Analysis population included all eligible participants whose data were included and observed in this study. This outcome measure was planned to be reported for unmatched participants (treated and untreated). | Participants | COUNT_OF_PARTICIPANTS |
| PRIMARY | Number of Participants According to Industry Type: Matched Participants | At index date (any date during index date identification period of approximately 11.5 months); retrospective data collected was evaluated in 0.5 months of this study | Analysis population included all eligible participants whose data were retrieved and observed in this study. This outcome measure was planned to be reported for matched participants (treated and untreated). Here, Overall Number of Participants Analyzed signifies the numbers which were matched/ adjusted based on pre-defined characteristics among actual enrolled population and was a pseudo population, hence these numbers are different from unmatched population (actual enrolled population). | Participants | COUNT_OF_PARTICIPANTS |
| PRIMARY | Number of Participants According to Quarter (Q) of Index Year: Unmatched Participants | At index date (any date during index date identification period of approximately 11.5 months); retrospective data collected was evaluated in 0.5 months of this study | Analysis population included all eligible participants whose data were included and observed in this study. This outcome measure was planned to be reported for unmatched participants (treated and untreated). | Participants | COUNT_OF_PARTICIPANTS |
| PRIMARY | Number of Participants According to Quarter of Index Year: Matched Participants | At index date (any date during index date identification period of approximately 11.5 months); retrospective data collected was evaluated in 0.5 months of this study | Analysis population included all eligible participants whose data were retrieved and observed in this study. This outcome measure was planned to be reported for matched participants (treated and untreated). Here, Overall Number of Participants Analyzed signifies the numbers which were matched/ adjusted based on pre-defined characteristics among actual enrolled population and was a pseudo population, hence these numbers are different from unmatched population (actual enrolled population). | Participants | COUNT_OF_PARTICIPANTS |
| PRIMARY | Mean Duration of Follow-up: Unmatched Participants | From index date to the end of follow-up (maximum follow-up was up to an average of 8.3 months during data observation of approximately 1.5 years); retrospective data collected was evaluated in 0.5 months of this study | Analysis population included all eligible participants whose data were included and observed in this study. This outcome measure was planned to be reported for unmatched participants (treated and untreated). | Months | MEAN |
| PRIMARY | Mean Duration of Follow-up: Matched Participants | From index date to the end of follow-up (maximum follow-up was up to an average of 8.3 months during data observation of approximately 1.5 years); retrospective data collected was evaluated in 0.5 months of this study | Analysis population included all eligible participants whose data were retrieved and observed in this study. This outcome measure was planned to be reported for matched participants (treated and untreated). Here, Overall Number of Participants Analyzed signifies the numbers which were matched/ adjusted based on pre-defined characteristics among actual enrolled population and was a pseudo population, hence these numbers are different from unmatched population (actual enrolled population). | Months | MEAN |
| PRIMARY | Mean Elixhauser Comorbidity Index (ECI): Unmatched Participants | Pre-period (6 months period before index date; during data observation of approximately 1.5 years); retrospective data collected was evaluated in 0.5 months of this study | Analysis population included all eligible participants whose data were included and observed in this study. This outcome measure was planned to be reported for unmatched participants (treated and untreated). | Units on a scale | MEAN |
| PRIMARY | Mean ECI: Matched Participants | Pre-period (6 months period before index date; during data observation of approximately 1.5 years); retrospective data collected was evaluated in 0.5 months of this study | Analysis population included all eligible participants whose data were retrieved and observed in this study. This outcome measure was planned to be reported for matched participants (treated and untreated). Here, Overall Number of Participants Analyzed signifies the numbers which were matched/ adjusted based on pre-defined characteristics among actual enrolled population and was a pseudo population, hence these numbers are different from unmatched population (actual enrolled population). | Units on a scale | MEAN |
| PRIMARY | Mean Charlson Comorbidity Index (CCI): Unmatched Participants | Pre-period (6 months period before index date; during data observation of approximately 1.5 years); retrospective data collected was evaluated in 0.5 months of this study | Analysis population included all eligible participants whose data were included and observed in this study. This outcome measure was planned to be reported for unmatched participants (treated and untreated). | Units on a scale | MEAN |
| PRIMARY | Mean CCI: Matched Participants | Pre-period (6 months period before index date; during data observation of approximately 1.5 years); retrospective data collected was evaluated in 0.5 months of this study | Analysis population included all eligible participants whose data were retrieved and observed in this study. This outcome measure was planned to be reported for matched participants (treated and untreated). Here, Overall Number of Participants Analyzed signifies the numbers which were matched/ adjusted based on pre-defined characteristics among actual enrolled population and was a pseudo population, hence these numbers are different from unmatched population (actual enrolled population). | Units on a scale | MEAN |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT07072793/outcomes